<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">mimmun</journal-id><journal-title-group><journal-title xml:lang="ru">Медицинская иммунология</journal-title><trans-title-group xml:lang="en"><trans-title>Medical Immunology (Russia)</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">1563-0625</issn><issn pub-type="epub">2313-741X</issn><publisher><publisher-name>SPb RAACI</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.15789/1563-0625-2016-6-537-544</article-id><article-id custom-type="elpub" pub-id-type="custom">mimmun-1134</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ОРИГИНАЛЬНЫЕ СТАТЬИ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>ORIGINAL ARTICLES</subject></subj-group></article-categories><title-group><article-title>ХАРАКТЕРИСТИКА ПРОФИЛЯ ПРОВОСПАЛИТЕЛЬНЫХ ЦИТОКИНОВ У БОЛЬНЫХ С РАЗЛИЧНЫМИ ФЕНОТИПАМИ АЛЬФА-1-АНТИТРИПСИНА</article-title><trans-title-group xml:lang="en"><trans-title>PROINFLAMMATORY CYTOKINE PROFILE IN PATIENTS WITH DIFFERENT ALPHA-1-ANTITRYPSIN PHENOTYPES</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Первакова</surname><given-names>М. Ю.</given-names></name><name name-style="western" xml:lang="en"><surname>Pervakova</surname><given-names>M. Yu.</given-names></name></name-alternatives><bio xml:lang="ru"><p>врач клинической лабораторной диагностики лаборатории диагностики аутоиммунных заболеваний НМЦ по молекулярной медицине </p></bio><bio xml:lang="en"><p>Laboratory Doctor, Diagnostic Laboratory for Autoimmune Disorders, Research Center of Molecular Medicine</p></bio><email xlink:type="simple">margaritalerner@gmail.com</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Лапин</surname><given-names>С. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Lapin</surname><given-names>S. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>к.м.н., старший научный сотрудник, заведующий лабораторией диагностики аутоиммунных заболеваний НМЦ по молекулярной медицине</p></bio><bio xml:lang="en"><p>PhD (Medicine), Senior Research Associate, Head, Laboratory for Diagnostics of Autoimmune Diseases, Research Center of Molecular Medicine</p></bio><email xlink:type="simple">margaritalerner@gmail.com</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Суркова</surname><given-names>Е. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Surkova</surname><given-names>E. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>к.б.н., старший научный сотрудник лаборатории диагностики аутоиммунных заболеваний НМЦ по молекулярной медицине </p></bio><bio xml:lang="en"><p>PhD (Biology), Senior Research Associate, Laboratory for Diagnostics of Autoimmune Diseases, Research Center of Molecular Medicine</p></bio><email xlink:type="simple">margaritalerner@gmail.com</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Ткаченко</surname><given-names>О. Ю.</given-names></name><name name-style="western" xml:lang="en"><surname>Tkachenko</surname><given-names>O. Yu.</given-names></name></name-alternatives><bio xml:lang="ru"><p>лаборант, лаборатория диагностики аутоиммунных заболеваний НМЦ по молекулярной медицине</p></bio><bio xml:lang="en"><p>Laboratory Assistant, Laboratory for Diagnostics of Autoimmune Diseases, Research Center of Molecular Medicine</p></bio><email xlink:type="simple">margaritalerner@gmail.com</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Будкова</surname><given-names>А. И.</given-names></name><name name-style="western" xml:lang="en"><surname>Budkova</surname><given-names>A. I.</given-names></name></name-alternatives><bio xml:lang="ru"><p>студент </p></bio><bio xml:lang="en"><p>Student,</p></bio><email xlink:type="simple">margaritalerner@gmail.com</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Гусева</surname><given-names>В. И.</given-names></name><name name-style="western" xml:lang="en"><surname>Guseva</surname><given-names>V. I.</given-names></name></name-alternatives><bio xml:lang="ru"><p>лаборант, лаборатория диагностики аутоиммунных заболеваний НМЦ по молекулярной медицине</p></bio><bio xml:lang="en"><p>Laboratory Assistant, Laboratory for Diagnostics of Autoimmune Diseases, Research Center of Molecular Medicine</p></bio><email xlink:type="simple">margaritalerner@gmail.com</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Титова</surname><given-names>О. Н.</given-names></name><name name-style="western" xml:lang="en"><surname>Titova</surname><given-names>O. N.</given-names></name></name-alternatives><bio xml:lang="ru"><p>д.м.н., профессор, директор НИИ пульмонологии Г</p></bio><bio xml:lang="en"><p>PhD, MD (Medicine), Professor, Director, Research Institute of Pulmonology</p></bio><email xlink:type="simple">margaritalerner@gmail.com</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Эмануэль</surname><given-names>В. Л.</given-names></name><name name-style="western" xml:lang="en"><surname>Emanuel</surname><given-names>V. L.</given-names></name></name-alternatives><bio xml:lang="ru"><p> </p><p>д.м.н., профессор, заведующий кафедрой клинической лабораторной диагностики с курсом молекулярной медицины</p></bio><bio xml:lang="en"><p>PhD, MD (Medicine), Professor, Head, Department of Clinical Laboratory Diagnostics with a Course of Molecular Medicine</p></bio><email xlink:type="simple">margaritalerner@gmail.com</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Тотолян</surname><given-names>Арег А.</given-names></name><name name-style="western" xml:lang="en"><surname>Totolian</surname><given-names>Areg A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>д.м.н., член-корр. РАН, профессор, директор Санкт-Петербургского научно-исследовательского института эпидемиологии и микробиологии им. Пастера</p></bio><bio xml:lang="en"><p>PhD, MD (Medicine), Professor, Corresponding Member, Russian Academy of Sciences, Director</p></bio><email xlink:type="simple">margaritalerner@gmail.com</email><xref ref-type="aff" rid="aff-2"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>ГБОУ ВПО «Первый Санкт-Петербургский государственный медицинский университет имени академика И.П. Павлова» Министерства здравоохранения РФ, Санкт-Петербург, Россия</institution><country>Россия</country></aff><aff xml:lang="en"><institution>The First St. Petersburg I. Pavlov State Medical University, St. Petersburg, Russian Federation</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru"><institution>ГБОУ ВПО «Первый Санкт-Петербургский государственный медицинский университет имени академика И.П. Павлова» Министерства здравоохранения РФ, Санкт-Петербург, Россия  &#13;
Санкт-Петербургский научно-исследовательский институт эпидемиологии и микробиологии им. Пастера, Санкт-Петербург, Россия</institution><country>Россия</country></aff><aff xml:lang="en"><institution>The First St. Petersburg I. Pavlov State Medical University, St. Petersburg, Russian Federation  &#13;
St. Petersburg Pasteur Institute, St. Petersburg, Russian Federation</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2016</year></pub-date><pub-date pub-type="epub"><day>07</day><month>12</month><year>2016</year></pub-date><volume>18</volume><issue>6</issue><fpage>537</fpage><lpage>544</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Первакова М.Ю., Лапин С.В., Суркова Е.А., Ткаченко О.Ю., Будкова А.И., Гусева В.И., Титова О.Н., Эмануэль В.Л., Тотолян А., 2016</copyright-statement><copyright-year>2016</copyright-year><copyright-holder xml:lang="ru">Первакова М.Ю., Лапин С.В., Суркова Е.А., Ткаченко О.Ю., Будкова А.И., Гусева В.И., Титова О.Н., Эмануэль В.Л., Тотолян А.</copyright-holder><copyright-holder xml:lang="en">Pervakova M.Y., Lapin S.V., Surkova E.A., Tkachenko O.Y., Budkova A.I., Guseva V.I., Titova O.N., Emanuel V.L., Totolian A.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.mimmun.ru/mimmun/article/view/1134">https://www.mimmun.ru/mimmun/article/view/1134</self-uri><abstract><p>Альфа-1-антитрипсин (А1АТ) обладает широким спектром защитных эффектов, направленных на уменьшение вторичного повреждения при воспалении. Помимо ингибирования сериновых протеаз, А1АТ осуществляет регуляцию продукции провоспалительных цитокинов. Известно большое количество фенотипических вариантов А1АТ, которые могут изменять цитокиновый профиль при воспалительном процессе и повышать риск ассоциированных с дефицитом А1АТ заболеваний.</p><p>Целью нашего исследования являлась оценка цитокинового профиля у больных с различными фенотипами А1АТ.</p><p>Было собрано 86 образцов сыворотки крови больных с подозрением на дефицит А1АТ, в которых были определены фенотипы и концентрации А1АТ. В зависимости от фенотипа образцы были разделены на четыре группы: с PiMM, PiZZ, PiMZ и редкими фенотипами А1АТ. В этих группах были измерены уровни IFNγ, TNFα, IL-6, IL-8 и IL-17 методом иммуноферментного анализа с помощью коммерческих тест-систем производства ООО «Цитокин» (Россия).</p><p>Уровень IL-6 оказался повышен в группе с PiZZ-фенотипом и составил 73,52±4,363 pg/ml, тогда как при PiMM-фенотипе среднее значение IL-6 было 45,61±8,012 pg/ml, p &lt; 0,05. Также в группах с PiZZ- и PiMZ-фенотипами было обнаружено повышение IL-17 по сравнению с PiMM-фенотипом (p &lt; 0,001). Средние значения IL-17 у больных с PiZZ-, PiMZ- и PiMM-фенотипами составили 80,13±13,56 pg/ml, 106,7±26,28 pg/ml и 42,73±18,52 pg/ml соответственно. При этом уровни IL-8, IFNγ и TNFα не отличались при различных фенотипах А1АТ. Результаты нашего исследования позволяют сделать заключение, что дисбаланс цитокинов может играть важную роль в возникновении ассоциированных с дефицитом А1АТ заболеваний.</p><p> </p></abstract><trans-abstract xml:lang="en"><p>Alpha-1-antitrypsin (A1AT) exerts a wide spectrum of protective effects, being focused on reduction of secondary injury in inflammation. Moreover, A1AT inhibits some serine proteases, and down-regulates production of proinflammatory cytokines. A number of known A1AT phenotypes is accompanied by affection of cytokine profile in inflammatory processes, thus increasing the risk of disorders associated with A1AT deficiency.</p><p>The aim of our study was to evaluate cytokine profiles in the patients with different A1AT phenotypes. Were collected eighty-six blood sera from the persons with suspected A1AT deficiency. The A1AT phenotypes </p><p>and concentrations were determined in these samples. The patients were divided into four groups, depending on their A1AT variants, i.e., PiMM, PiZZ, PiMZ and rare A1AT phenotypes. The serum levels of IFNγ, TNFα, IL-6, IL-8, and IL-17 were measured in these groups by means of ELISA technique.</p><p>The mean levels of IL-6 comprised 73.52±4.363 pg/ml in the patients with PiZZ phenotype, being higher than in cases of PiMM phenotype (45.61±8.01 pg/ml, p &lt; 0.05). The IL-17 levels were also found to be increased in the groups with PiZZ and PiMZ phenotypes, as compared with PiMM phenotype (p &lt; 0.001). The mean IL-17 values in the samples with PiZZ, PiMZ, and PiMM phenotypes were 80.13±13.56 pg/ml, 106.7±26.28 pg/ml and 42.73±18.52 pg/ml, respectively. Meanwhile, there were no significant differences in IL-8, IFNγ and TNFα levels among different A1AT phenotypes. </p><p>The results of this study let us conclude that the cytokine imbalance may be crucial to onset of diseases associated with A1AT deficiency.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>воспаление</kwd><kwd>альфа-1-антитрипсин</kwd><kwd>цитокин</kwd><kwd>фенотип альфа-1-антитрипсина</kwd><kwd>дефицит альфа-1-антитрипсина</kwd></kwd-group><kwd-group xml:lang="en"><kwd>inflammation</kwd><kwd>alpha-1-antitrypsin</kwd><kwd>cytokine</kwd><kwd>alpha-1-antitrypsin phenotype</kwd><kwd>alpha-1-antitrypsin deficiency</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Шевченко О.П. Белки острой фазы воспаления. Лаборатория, 1996, № 1. С. 10-17. [Shevchenko O.P. Acute phase proteins. Laboratoriya = Laboratory, 1996, no. 1, pp. 10-17. (In Russ.])</mixed-citation><mixed-citation xml:lang="en">Шевченко О.П. Белки острой фазы воспаления. Лаборатория, 1996, № 1. С. 10-17. [Shevchenko O.P. Acute phase proteins. Laboratoriya = Laboratory, 1996, no. 1, pp. 10-17. (In Russ.])</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Stoller J.K., Lacbawan F.L., Aboussouan L.S. Alpha-1 antitrypsin deﬁciency. Gene reviews, 2006.</mixed-citation><mixed-citation xml:lang="en">Stoller J.K., Lacbawan F.L., Aboussouan L.S. Alpha-1 antitrypsin deﬁciency. Gene reviews, 2006.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Lockett A.D., van Demark M., Gu Y., Schweitzer K.S., Sigua N., Kamocki K., Fijalkowska I., Garrison J., Fisher A.J., Serban K., Wise R.A., Flotte T.R., Mueller C., Presson R.G.Jr., Petrache H.I., Tuder R.M., Petrache I. Eﬀect of cigarette smoke exposure and structural modiﬁcations on the alpha-1 Antitrypsin interaction with caspases. Mol. Med., 2012, Vol. 18, pp. 445-454.</mixed-citation><mixed-citation xml:lang="en">Lockett A.D., van Demark M., Gu Y., Schweitzer K.S., Sigua N., Kamocki K., Fijalkowska I., Garrison J., Fisher A.J., Serban K., Wise R.A., Flotte T.R., Mueller C., Presson R.G.Jr., Petrache H.I., Tuder R.M., Petrache I. Eﬀect of cigarette smoke exposure and structural modiﬁcations on the alpha-1 Antitrypsin interaction with caspases. Mol. Med., 2012, Vol. 18, pp. 445-454.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Feng Y., Xu J., Zhou Q., Wang R., Liu N., Wu Y., Yuan H., Che H. Alpha-1 Antitrypsin prevents the development of preeclampsia through suppression of oxidative stress. Front Physiol., 2016, Vol. 7, p. 176.</mixed-citation><mixed-citation xml:lang="en">Feng Y., Xu J., Zhou Q., Wang R., Liu N., Wu Y., Yuan H., Che H. Alpha-1 Antitrypsin prevents the development of preeclampsia through suppression of oxidative stress. Front Physiol., 2016, Vol. 7, p. 176.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Stockley R.A. The multiple facets of alpha-1-antitrypsin. Ann. Transl. Med., 2015, Vol. 3, no. 10, p. 130.</mixed-citation><mixed-citation xml:lang="en">Stockley R.A. The multiple facets of alpha-1-antitrypsin. Ann. Transl. Med., 2015, Vol. 3, no. 10, p. 130.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Zampronio A.R., Soares D.M., Souza G.E. Central mediators involved in the febrile response: eﬀects of antipyretic drugs. Temperature (Austin), 2015, Vol. 2, no. 4, pp. 506-521.</mixed-citation><mixed-citation xml:lang="en">Zampronio A.R., Soares D.M., Souza G.E. Central mediators involved in the febrile response: eﬀects of antipyretic drugs. Temperature (Austin), 2015, Vol. 2, no. 4, pp. 506-521.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Koo J.B., Han J.S. Cigarette smoke extract-induced interleukin-6 expression is regulated by phospholipase D1 in human bronchial epithelial cells. J. Toxicol. Sci., 2016, Vol. 41, no. 1, pp. 77-89.</mixed-citation><mixed-citation xml:lang="en">Koo J.B., Han J.S. Cigarette smoke extract-induced interleukin-6 expression is regulated by phospholipase D1 in human bronchial epithelial cells. J. Toxicol. Sci., 2016, Vol. 41, no. 1, pp. 77-89.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">de Carvalho F.O., Felipe F.A., de Melo Costa A.C., Teixeira L.G., Silva É.R., Nunes P.S., Shanmugam S., de Lucca Junior W., Quintans J.S., de Souza Araújo A.A. Inﬂammatory mediators and oxidative stress in animals subjected to smoke inhalation: a systematic review. Lung, 2016.</mixed-citation><mixed-citation xml:lang="en">de Carvalho F.O., Felipe F.A., de Melo Costa A.C., Teixeira L.G., Silva É.R., Nunes P.S., Shanmugam S., de Lucca Junior W., Quintans J.S., de Souza Araújo A.A. Inﬂammatory mediators and oxidative stress in animals subjected to smoke inhalation: a systematic review. Lung, 2016.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Ansarin K., Rashidi F., Namdar H., Ghaﬀari M., Shariﬁ A. Echocardiographic evaluation of the relationship between inﬂammatory factors (IL6, TNFalpha, hs-CRP) and secondary pulmonary hypertension in patients with COPD. A Cross Sectional Study. Pneumologia, 2015, Vol. 64, no. 3, pp. 31-35.</mixed-citation><mixed-citation xml:lang="en">Ansarin K., Rashidi F., Namdar H., Ghaﬀari M., Shariﬁ A. Echocardiographic evaluation of the relationship between inﬂammatory factors (IL6, TNFalpha, hs-CRP) and secondary pulmonary hypertension in patients with COPD. A Cross Sectional Study. Pneumologia, 2015, Vol. 64, no. 3, pp. 31-35.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Chen Z., Shao X., Dou X., Zhang X., Wang Y., Zhu C., Hao C., Fan M., Ji W., Yan Y. Role of the mycoplasma pneumoniae/interleukin-8/neutrophil axis in the pathogenesis of pneumonia. PLoS One, 2016, Vol. 11, no. 1, p. e0146377.</mixed-citation><mixed-citation xml:lang="en">Chen Z., Shao X., Dou X., Zhang X., Wang Y., Zhu C., Hao C., Fan M., Ji W., Yan Y. Role of the mycoplasma pneumoniae/interleukin-8/neutrophil axis in the pathogenesis of pneumonia. PLoS One, 2016, Vol. 11, no. 1, p. e0146377.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Majak P. Tumor necrosis factor alpha as an asthma biomarker in early childhood. Pneumonol. Alergol. Pol., 2016, Vol. 84, no. 3, pp. 143-144.</mixed-citation><mixed-citation xml:lang="en">Majak P. Tumor necrosis factor alpha as an asthma biomarker in early childhood. Pneumonol. Alergol. Pol., 2016, Vol. 84, no. 3, pp. 143-144.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Cosmi L., Liotta F., Annunziato F. Th17 regulating lower airway disease. Curr Opin Allergy Clin. Immunol., 2016, Vol. 16, no. 1, pp. 1-6.</mixed-citation><mixed-citation xml:lang="en">Cosmi L., Liotta F., Annunziato F. Th17 regulating lower airway disease. Curr Opin Allergy Clin. Immunol., 2016, Vol. 16, no. 1, pp. 1-6.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Miossec P., Korn T., Kuchroo V.K. Interleukin-17 and type 17 helper T cells. N. Engl. J. Med., 2009, Vol. 361, no. 9, pp. 888-898.</mixed-citation><mixed-citation xml:lang="en">Miossec P., Korn T., Kuchroo V.K. Interleukin-17 and type 17 helper T cells. N. Engl. J. Med., 2009, Vol. 361, no. 9, pp. 888-898.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Ortiz G, Salica J.P., Chuluyan E.H., Gallo J.E. Diabetic retinopathy: could the alpha-1 antitrypsin be a therapeutic option? Biol. Res., 2014, Vol. 47, p. 58.</mixed-citation><mixed-citation xml:lang="en">Ortiz G, Salica J.P., Chuluyan E.H., Gallo J.E. Diabetic retinopathy: could the alpha-1 antitrypsin be a therapeutic option? Biol. Res., 2014, Vol. 47, p. 58.</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Lewis E.C., Shapiro L., Bowers O.J., Dinarello C.A. Alpha1-antitrypsin monotherapy prolongs islet allograﬅ survival in mice. Proc. Natl. Acad. Sci. USA, 2005, Vol. 102, no. 34, pp. 12153-12158.</mixed-citation><mixed-citation xml:lang="en">Lewis E.C., Shapiro L., Bowers O.J., Dinarello C.A. Alpha1-antitrypsin monotherapy prolongs islet allograﬅ survival in mice. Proc. Natl. Acad. Sci. USA, 2005, Vol. 102, no. 34, pp. 12153-12158.</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Subramaniyam D., Virtala R., Pawłowski K., Clausen I.G., Warkentin S., Stevens T., Janciauskiene S. TNF-alpha-induced self expression in human lung endothelial cells is inhibited by native and oxidized alpha1-antitrypsin. Int. J. Biochem. Cell Biol., 2008, Vol. 40, no. 2, pp. 258-271.</mixed-citation><mixed-citation xml:lang="en">Subramaniyam D., Virtala R., Pawłowski K., Clausen I.G., Warkentin S., Stevens T., Janciauskiene S. TNF-alpha-induced self expression in human lung endothelial cells is inhibited by native and oxidized alpha1-antitrypsin. Int. J. Biochem. Cell Biol., 2008, Vol. 40, no. 2, pp. 258-271.</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Bergin D.A., Reeves E.P., Hurley K., Wolfe R., Jameel R., Fitzgerald S., McElvaney N.G. The circulating proteinase inhibitor alpha-1 antitrypsin regulates neutrophil degranulation and autoimmunity. Sci. Transl. Med., 2014, Vol. 6, no. 217, p. 217ra1.</mixed-citation><mixed-citation xml:lang="en">Bergin D.A., Reeves E.P., Hurley K., Wolfe R., Jameel R., Fitzgerald S., McElvaney N.G. The circulating proteinase inhibitor alpha-1 antitrypsin regulates neutrophil degranulation and autoimmunity. Sci. Transl. Med., 2014, Vol. 6, no. 217, p. 217ra1.</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Pott G.B., Chan E.D., Dinarello C.A., Shapiro L. Alpha-1-antitrypsin is an endogenous inhibitor of proinﬂammatory cytokine production in whole blood. J. Leukoc. Biol., 2009, Vol. 85, no. 5, pp. 886-895.</mixed-citation><mixed-citation xml:lang="en">Pott G.B., Chan E.D., Dinarello C.A., Shapiro L. Alpha-1-antitrypsin is an endogenous inhibitor of proinﬂammatory cytokine production in whole blood. J. Leukoc. Biol., 2009, Vol. 85, no. 5, pp. 886-895.</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Subramanian S., Shahaf G., Ozeri E., Miller L.M., Vandenbark A.A., Lewis E.C., Oﬀner H. Sustained expression of circulating human alpha-1 antitrypsin reduces inﬂammation, increases CD4+FoxP3+ Treg cell population and prevents signs of experimental autoimmune encephalomyelitis in mice. Metab. Brain Dis., 2011, Vol. 26, no. 2, pp. 107-113.</mixed-citation><mixed-citation xml:lang="en">Subramanian S., Shahaf G., Ozeri E., Miller L.M., Vandenbark A.A., Lewis E.C., Oﬀner H. Sustained expression of circulating human alpha-1 antitrypsin reduces inﬂammation, increases CD4+FoxP3+ Treg cell population and prevents signs of experimental autoimmune encephalomyelitis in mice. Metab. Brain Dis., 2011, Vol. 26, no. 2, pp. 107-113.</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Stone H., McNab G., Wood A.M., Stockley R.A., Sapey E. Variability of sputum inﬂammatory mediators in COPD and alpha1-antitrypsin deﬁciency. Eur. Respir. J., 2012, Vol. 40, no. 3, pp. 561-569.</mixed-citation><mixed-citation xml:lang="en">Stone H., McNab G., Wood A.M., Stockley R.A., Sapey E. Variability of sputum inﬂammatory mediators in COPD and alpha1-antitrypsin deﬁciency. Eur. Respir. J., 2012, Vol. 40, no. 3, pp. 561-569.</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Seixas S., Garcia O., Trovoada M.J., Santos M.T., Amorim A., Rocha J. Patterns of haplotype diversity within the serpin gene cluster at 14q32.1: insights into the natural history of the alpha1-antitrypsin polymorphism. Hum. Genet., 2001, Vol. 108, no. 1, pp. 20-30.</mixed-citation><mixed-citation xml:lang="en">Seixas S., Garcia O., Trovoada M.J., Santos M.T., Amorim A., Rocha J. Patterns of haplotype diversity within the serpin gene cluster at 14q32.1: insights into the natural history of the alpha1-antitrypsin polymorphism. Hum. Genet., 2001, Vol. 108, no. 1, pp. 20-30.</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Keren D.F. Protein electrophoresis in clinical diagnosis. Ed. A. London, 2003, pp. 71-77.</mixed-citation><mixed-citation xml:lang="en">Keren D.F. Protein electrophoresis in clinical diagnosis. Ed. A. London, 2003, pp. 71-77.</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Salahuddin P. Genetic variants of alpha1-antitrypsin. Curr. Protein Pept. Sci., 2010, Vol. 11, no. 2, pp. 101-117.</mixed-citation><mixed-citation xml:lang="en">Salahuddin P. Genetic variants of alpha1-antitrypsin. Curr. Protein Pept. Sci., 2010, Vol. 11, no. 2, pp. 101-117.</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">Olfert I.M., Malek M.H., Eagan T.M., Wagner H., Wagner P.D. Inﬂammatory cytokine response to exercise in alpha-1-antitrypsin deﬁcient COPD patients ‘on’ or ‘oﬀ’ augmentation therapy. BMC Pulm. Med., 2014, Vol. 14, p. 106.</mixed-citation><mixed-citation xml:lang="en">Olfert I.M., Malek M.H., Eagan T.M., Wagner H., Wagner P.D. Inﬂammatory cytokine response to exercise in alpha-1-antitrypsin deﬁcient COPD patients ‘on’ or ‘oﬀ’ augmentation therapy. BMC Pulm. Med., 2014, Vol. 14, p. 106.</mixed-citation></citation-alternatives></ref><ref id="cit25"><label>25</label><citation-alternatives><mixed-citation xml:lang="ru">Pervakova M.Yu., Emanuel V.L., Titova O.N., Lapin S.V., Mazurov V.I., Belyaeva I.B., Chudinov A.L., Blinova T.V., Surkova E.A. The diagnostic value of alpha-1-antitrypsin phenotype in Patients with granulomatosis with polyangiitis. International Journal of Rheumatology, 2016, pp. 1-5.</mixed-citation><mixed-citation xml:lang="en">Pervakova M.Yu., Emanuel V.L., Titova O.N., Lapin S.V., Mazurov V.I., Belyaeva I.B., Chudinov A.L., Blinova T.V., Surkova E.A. The diagnostic value of alpha-1-antitrypsin phenotype in Patients with granulomatosis with polyangiitis. International Journal of Rheumatology, 2016, pp. 1-5.</mixed-citation></citation-alternatives></ref><ref id="cit26"><label>26</label><citation-alternatives><mixed-citation xml:lang="ru">Pervakova M.Y., Emanuel V.L., Surkova E.A., Mazing A.V., Lapin S.V., Kovaleva I.S., Sysoeva S.N. The comparison of techniques of electrophoresis, immune turbidynamic measurement and phenotyping of alpha-1-antitrypsin for diagnostic of alpha-1-antitrypsin insufficiency. Clin. Lab. Diagn., 2015, Vol. 10, pp. 28-32.</mixed-citation><mixed-citation xml:lang="en">Pervakova M.Y., Emanuel V.L., Surkova E.A., Mazing A.V., Lapin S.V., Kovaleva I.S., Sysoeva S.N. The comparison of techniques of electrophoresis, immune turbidynamic measurement and phenotyping of alpha-1-antitrypsin for diagnostic of alpha-1-antitrypsin insufficiency. Clin. Lab. Diagn., 2015, Vol. 10, pp. 28-32.</mixed-citation></citation-alternatives></ref><ref id="cit27"><label>27</label><citation-alternatives><mixed-citation xml:lang="ru">Mahr A.D., Edberg J.C., Stone J.H., Hoﬀman G.S., St Clair E.W., Specks U., Dellaripa P.F., Seo P., Spiera R.F., Rouhani F.N., Brantly M.L., Merkel P.A. Alpha(1)-antitrypsin deﬁciency-related alleles Z and S and the risk of Wegener’s granulomatosis. Arthritis Rheum., 2010, Vol. 62, no. 12, pp. 3760-3767.</mixed-citation><mixed-citation xml:lang="en">Mahr A.D., Edberg J.C., Stone J.H., Hoﬀman G.S., St Clair E.W., Specks U., Dellaripa P.F., Seo P., Spiera R.F., Rouhani F.N., Brantly M.L., Merkel P.A. Alpha(1)-antitrypsin deﬁciency-related alleles Z and S and the risk of Wegener’s granulomatosis. Arthritis Rheum., 2010, Vol. 62, no. 12, pp. 3760-3767.</mixed-citation></citation-alternatives></ref><ref id="cit28"><label>28</label><citation-alternatives><mixed-citation xml:lang="ru">American Thoracic Society/European Respiratory Society statement: standards for the diagnosis and management of individuals with alpha-1 antitrypsin deﬁciency. Am. J. Respir. Crit. Care Med., 2003, Vol. 168, no. 7, pp. 818-900.</mixed-citation><mixed-citation xml:lang="en">American Thoracic Society/European Respiratory Society statement: standards for the diagnosis and management of individuals with alpha-1 antitrypsin deﬁciency. Am. J. Respir. Crit. Care Med., 2003, Vol. 168, no. 7, pp. 818-900.</mixed-citation></citation-alternatives></ref><ref id="cit29"><label>29</label><citation-alternatives><mixed-citation xml:lang="ru">Duan M.C., Zhang J.Q., Liang Y., Liu G.N., Xiao J., Tang H.J., Liang Y. Inﬁltration of IL-17-producing T cells and Treg cells in a mouse model of smoke-induced emphysema. Inﬂammation, 2016.</mixed-citation><mixed-citation xml:lang="en">Duan M.C., Zhang J.Q., Liang Y., Liu G.N., Xiao J., Tang H.J., Liang Y. Inﬁltration of IL-17-producing T cells and Treg cells in a mouse model of smoke-induced emphysema. Inﬂammation, 2016.</mixed-citation></citation-alternatives></ref><ref id="cit30"><label>30</label><citation-alternatives><mixed-citation xml:lang="ru">Singh D. Chronic Obstructive Pulmonary Disease, Neutrophils and Bacterial Infection: A complex web involving IL-17 and IL-22 unravels. EBioMedicine, 2015, Vol. 2, no. 11, pp. 1580-1581.</mixed-citation><mixed-citation xml:lang="en">Singh D. Chronic Obstructive Pulmonary Disease, Neutrophils and Bacterial Infection: A complex web involving IL-17 and IL-22 unravels. EBioMedicine, 2015, Vol. 2, no. 11, pp. 1580-1581.</mixed-citation></citation-alternatives></ref><ref id="cit31"><label>31</label><citation-alternatives><mixed-citation xml:lang="ru">Chen Q.R., Wang L.F., Xia S.S., Zhang Y.M., Xu J.N., Li H., Ding Y.Z. Role of interleukin-17A in early graﬅ rejection aﬅer orthotopic lung transplantation in mice. J. Thorac. Dis., 2016, Vol. 8, no. 6, pp. 1069-1079.</mixed-citation><mixed-citation xml:lang="en">Chen Q.R., Wang L.F., Xia S.S., Zhang Y.M., Xu J.N., Li H., Ding Y.Z. Role of interleukin-17A in early graﬅ rejection aﬅer orthotopic lung transplantation in mice. J. Thorac. Dis., 2016, Vol. 8, no. 6, pp. 1069-1079.</mixed-citation></citation-alternatives></ref><ref id="cit32"><label>32</label><citation-alternatives><mixed-citation xml:lang="ru">Bergin D.A., Reeves E.P., Meleady P., Henry M., McElvaney O.J., Carroll T.P., Condron C., Chotirmall S.H., Clynes M., O’Neill S.J., McElvaney N.G. Alpha-1 Antitrypsin regulates human neutrophil chemotaxis induced by soluble immune complexes and IL-8. J Clin. Invest., 2010, Vol. 120, no. 12, pp. 4236-4250.</mixed-citation><mixed-citation xml:lang="en">Bergin D.A., Reeves E.P., Meleady P., Henry M., McElvaney O.J., Carroll T.P., Condron C., Chotirmall S.H., Clynes M., O’Neill S.J., McElvaney N.G. Alpha-1 Antitrypsin regulates human neutrophil chemotaxis induced by soluble immune complexes and IL-8. J Clin. Invest., 2010, Vol. 120, no. 12, pp. 4236-4250.</mixed-citation></citation-alternatives></ref><ref id="cit33"><label>33</label><citation-alternatives><mixed-citation xml:lang="ru">Aldonyte R., Eriksson S., Piitulainen E., Wallmark A., Janciauskiene S. Analysis of systemic biomarkers in COPD patients. COPD, 2004, Vol. 1, no. 2, pp. 155-164.</mixed-citation><mixed-citation xml:lang="en">Aldonyte R., Eriksson S., Piitulainen E., Wallmark A., Janciauskiene S. Analysis of systemic biomarkers in COPD patients. COPD, 2004, Vol. 1, no. 2, pp. 155-164.</mixed-citation></citation-alternatives></ref><ref id="cit34"><label>34</label><citation-alternatives><mixed-citation xml:lang="ru">Honda K., Wada H., Nakamura M., Nakamoto K., Inui T., Sada M., Koide T., Takata S., Yokoyama T., Saraya T., Kurai D., Ishii H., Goto H., Takizawa H. IL-17A synergistically stimulates TNF-alpha-induced IL-8 production in human airway epithelial cells: A potential role in amplifying airway inﬂammation. Exp. Lung. Res., 2016, Vol. 42, no. 4, pp. 205-216.</mixed-citation><mixed-citation xml:lang="en">Honda K., Wada H., Nakamura M., Nakamoto K., Inui T., Sada M., Koide T., Takata S., Yokoyama T., Saraya T., Kurai D., Ishii H., Goto H., Takizawa H. IL-17A synergistically stimulates TNF-alpha-induced IL-8 production in human airway epithelial cells: A potential role in amplifying airway inﬂammation. Exp. Lung. Res., 2016, Vol. 42, no. 4, pp. 205-216.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
